BSE Live
Sep 26, 16:00Prev. Close
1.49
Open Price
1.49
Bid Price (Qty.)
1.52 (40046)
Offer Price (Qty.)
1.53 (128948)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
Key Financial Ratios of Remedium Lifecare (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 0.04 | 3.25 | 15.07 | 2.99 | 1.33 | |
Diluted EPS (Rs.) | 0.04 | 3.25 | 15.07 | 2.99 | 1.33 | |
Cash EPS (Rs.) | 0.04 | 3.25 | 15.49 | 3.20 | 1.50 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 1.07 | 4.26 | 28.79 | 13.72 | 10.72 | |
Book Value [InclRevalReserve]/Share (Rs.) | 1.07 | 4.26 | 28.79 | 13.72 | 10.72 | |
Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue from Operations/Share (Rs.) | 5.52 | 400.96 | 1,416.21 | 1,402.20 | 250.09 | |
PBDIT/Share (Rs.) | 0.22 | 5.40 | 20.75 | 4.74 | 1.98 | |
PBIT/Share (Rs.) | 0.22 | 5.39 | 20.33 | 4.53 | 1.81 | |
PBT/Share (Rs.) | 0.09 | 5.01 | 20.54 | 4.24 | 1.81 | |
Net Profit/Share (Rs.) | 0.04 | 3.25 | 15.07 | 2.99 | 1.33 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 4.04 | 1.34 | 1.46 | 0.33 | 0.79 | |
PBIT Margin (%) | 4.02 | 1.34 | 1.43 | 0.32 | 0.72 | |
PBT Margin (%) | 1.64 | 1.24 | 1.45 | 0.30 | 0.72 | |
Net Profit Margin (%) | 0.68 | 0.80 | 1.06 | 0.21 | 0.53 | |
Return on Networth / Equity (%) | 3.53 | 76.19 | 52.35 | 21.82 | 12.45 | |
Return on Capital Employed (%) | 20.67 | 126.46 | 70.63 | 33.04 | 4.54 | |
Return on Assets (%) | 0.09 | 1.68 | 0.47 | 0.48 | 1.24 | |
Total Debt/Equity (X) | 26.36 | 1.34 | 0.00 | 0.00 | 2.72 | |
Asset Turnover Ratio (%) | 0.13 | 2.61 | 0.74 | 3.85 | 233.65 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 1.03 | 1.02 | 1.01 | 1.02 | 1.59 | |
Quick Ratio (X) | 0.85 | 0.95 | 1.00 | 0.64 | 1.46 | |
Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 11.46 | 28.97 | |
Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 1,213.41 | 1,149.86 | 243.68 | 48.42 | 25.53 | |
EV/Net Operating Revenue (X) | 5.45 | 0.28 | 0.48 | 0.10 | 0.28 | |
EV/EBITDA (X) | 134.94 | 21.14 | 32.62 | 28.39 | 35.81 | |
MarketCap/Net Operating Revenue (X) | 0.33 | 0.27 | 0.52 | 0.10 | 0.18 | |
Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Price/BV (X) | 1.70 | 25.46 | 25.62 | 10.10 | 4.11 | |
Price/Net Operating Revenue | 0.33 | 0.27 | 0.52 | 0.10 | 0.18 | |
Earnings Yield | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 |
05.08.2025
Remedium Lifeca Standalone June 2025 Net Sales at Rs 18.37 crore, down 76.35% Y-o-Y
24.06.2025
Remedium Lifeca Standalone March 2025 Net Sales at Rs 81.57 crore, down 94.21% Y-o-Y
26.11.2024
Remedium Lifeca Standalone September 2024 Net Sales at Rs 25.08 crore, down 94.65% Y-o-Y
19.08.2024
Remedium Lifeca Standalone June 2024 Net Sales at Rs 77.70 crore, down 76.49% Y-o-Y
05.08.2025
Remedium Lifeca Standalone June 2025 Net Sales at Rs 18.37 crore, down 76.35% Y-o-Y
24.06.2025
Remedium Lifeca Standalone March 2025 Net Sales at Rs 81.57 crore, down 94.21% Y-o-Y
26.11.2024
Remedium Lifeca Standalone September 2024 Net Sales at Rs 25.08 crore, down 94.65% Y-o-Y
19.08.2024
Remedium Lifeca Standalone June 2024 Net Sales at Rs 77.70 crore, down 76.49% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017